{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T13:29:17Z","timestamp":1768829357657,"version":"3.49.0"},"reference-count":28,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T00:00:00Z","timestamp":1556841600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI 097241"],"award-info":[{"award-number":["R01 AI 097241"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ruth L. Kirschstein National Research Service Award","award":["T32 AI125207"],"award-info":[{"award-number":["T32 AI125207"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Adenovirus type 7 (Ad7) infection is associated with acute respiratory disease (ARD), especially in military recruits living in close quarters. Recently, several outbreaks of Ad7 infections have occurred in civilian populations, with some cases leading to death. However, the current Ad7 vaccine is licensed for use only in military recruits because it utilizes an orally delivered wild type virus which is shed in the stool for 28 days after immunization. This poses a safety risk due to the possibility of virus spread to vulnerable populations. To address the need for a safer Ad7 vaccine for use in civilian populations, we developed a single-cycle Ad7 virus (scAd7). This scAd7 virus is deleted for the Ad7 fiber protein, so that viruses produced outside of complementing cells lines lack this essential structural protein and have severely reduced infectivity. In vitro studies in noncomplementing A549 cells showed that the scAd7 virus has genomic DNA replication kinetics and Ad7 hexon expression similar to a replication-competent virus; however, virus progeny produced after infection has impaired infectivity. Therefore, this scAd7 virus combines the safety advantages of a replication-defective virus with the increased Ad7 gene expression of a replication-competent virus. Due to these advantages, we believe that scAd7 viruses should be further studied as an alternative, safer Adenovirus 7 vaccine.<\/jats:p>","DOI":"10.3390\/v11050413","type":"journal-article","created":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T03:15:46Z","timestamp":1557198946000},"page":"413","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A Single-Cycle Adenovirus Type 7 Vaccine for Prevention of Acute Respiratory Disease"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6702-0079","authenticated-orcid":false,"given":"Brianna L.","family":"Bullard","sequence":"first","affiliation":[{"name":"School of Biological Sciences, Nebraska Center for Virology, University of Nebraska, Lincoln, NE 68503, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9424-1398","authenticated-orcid":false,"given":"Brigette N.","family":"Corder","sequence":"additional","affiliation":[{"name":"School of Biological Sciences, Nebraska Center for Virology, University of Nebraska, Lincoln, NE 68503, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5029-0662","authenticated-orcid":false,"given":"Eric A.","family":"Weaver","sequence":"additional","affiliation":[{"name":"School of Biological Sciences, Nebraska Center for Virology, University of Nebraska, Lincoln, NE 68503, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,5,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1055\/s-0036-1584923","article-title":"Adenovirus: Epidemiology, global spread of novel serotypes, and advances in treatment and prevention","volume":"37","author":"Lynch","year":"2016","journal-title":"Semin. Respir. Crit Care Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1055\/s-0031-1283287","article-title":"Adenovirus","volume":"32","author":"Lynch","year":"2011","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.vaccine.2012.12.029","article-title":"History of the restoration of adenovirus type 4 and type 7 vaccine, live oral (adenovirus vaccine) in the context of the department of defense acquisition system","volume":"31","author":"Hoke","year":"2013","journal-title":"Vaccine"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4269\/ajtmh.2000.62.613","article-title":"Cost-effectiveness analysis of reacquiring and using adenovirus types 4 and 7 vaccines in naval recruits","volume":"62","author":"Hyer","year":"2000","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1016\/j.vaccine.2008.03.037","article-title":"A double-blind, placebo-controlled study of the safety and immunogenicity of live, oral type 4 and type 7 adenovirus vaccines in adults","volume":"26","author":"Lyons","year":"2008","journal-title":"Vaccine"},{"key":"ref_6","unstructured":"(2019, April 02). Adenovirus Type 4 and Type 7 Vaccine, Live, Oral Enteric Coated Tablets for Oral Administration [package insert], Available online: https:\/\/www.fda.gov\/media\/80211\/download."},{"key":"ref_7","unstructured":"(2019, April 02). NJDOH Confirms 11th Pediatric Death of Wanaque Patient, Available online: https:\/\/nj.gov\/health\/news\/2018\/approved\/20181116a.shtml."},{"key":"ref_8","unstructured":"(2019, April 02). Adenovirus: Director\u2019s Letter to Campus. Available online: https:\/\/health.umd.edu\/adenovirus-directors-letter-campus."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"7365","DOI":"10.1038\/srep07365","article-title":"Re-emergent human adenovirus genome type 7d caused an acute respiratory disease outbreak in southern china after a twenty-one year absence","volume":"4","author":"Zhao","year":"2014","journal-title":"Sci Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7883\/yoken.67.105","article-title":"Impact of human adenovirus serotype 7 in hospitalized children with severe fatal pneumonia in the philippines","volume":"67","author":"Yamamoto","year":"2014","journal-title":"Jpn. J. Infect. Dis"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s10096-007-0312-6","article-title":"High isolation rate of adenovirus serotype 7 from south korean military recruits with mild acute respiratory disease","volume":"26","author":"Jeon","year":"2007","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1128\/JCM.40.1.140-145.2002","article-title":"Molecular and epidemiological analyses of human adenovirus type 7 strains isolated from the 1995 nationwide outbreak in japan","volume":"40","author":"Noda","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1086\/320146","article-title":"Lower respiratory tract infections due to adenovirus in hospitalized korean children: Epidemiology, clinical features, and prognosis","volume":"32","author":"Hong","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Weaver, E.A., Nehete, P.N., Buchl, S.S., Senac, J.S., Palmer, D., Ng, P., Sastry, K.J., and Barry, M.A. (2009). Comparison of replication-competent, first generation, and helper-dependent adenoviral vaccines. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0005059"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1128\/JVI.73.2.907-919.1999","article-title":"Fiberless recombinant adenoviruses: Virus maturation and infectivity in the absence of fiber","volume":"73","author":"Legrand","year":"1999","journal-title":"J. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1128\/JVI.73.2.1601-1608.1999","article-title":"A helper-independent adenovirus vector with e1, e3, and fiber deleted: Structure and infectivity of fiberless particles","volume":"73","author":"Chiu","year":"1999","journal-title":"J. Virol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"6286","DOI":"10.1128\/JVI.00205-12","article-title":"A new human dsg2-transgenic mouse model for studying the tropism and pathology of human adenoviruses","volume":"86","author":"Wang","year":"2012","journal-title":"J. Virol."},{"key":"ref_18","first-page":"283","article-title":"Etiology of acute respiratory disease among service personnel at fort ord, california","volume":"62","author":"Berge","year":"1955","journal-title":"Am. J. Hyg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1128\/JVI.74.1.354-362.2000","article-title":"Adenovirus vector pseudotyping in fiber-expressing cell lines: Improved transduction of epstein-barr virus-transformed b cells","volume":"74","author":"Huang","year":"2000","journal-title":"J. Virol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1089\/hum.2013.215","article-title":"Cd46-mediated transduction of a species d adenovirus vaccine improves mucosal vaccine efficacy","volume":"25","author":"Camacho","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Weaver, E.A., Rubrum, A.M., Webby, R.J., and Barry, M.A. (2011). Protection against divergent influenza h1n1 virus by a centralized influenza hemagglutinin. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0018314"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CVI.00560-13","article-title":"Intramuscular delivery of adenovirus serotype 5 vector expressing humanized protective antigen induces rapid protection against anthrax that may bypass intranasally originated preexisting adenovirus immunity","volume":"21","author":"Wu","year":"2014","journal-title":"Clin. Vaccine Immunol. CVI"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nm.2270","article-title":"Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14","volume":"17","author":"Wang","year":"2010","journal-title":"Nat. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1128\/JVI.80.7.3549-3558.2006","article-title":"Replication properties of human adenovirus in vivo and in cultures of primary cells from different animal species","volume":"80","author":"Jogler","year":"2006","journal-title":"J. Virol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1099\/vir.0.81956-0","article-title":"Novel replication-incompetent adenoviral b-group vectors: High vector stability and yield in per.C6 cells","volume":"87","author":"Havenga","year":"2006","journal-title":"J. Gen. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e0181012","DOI":"10.1371\/journal.pone.0181012","article-title":"Human adenovirus type 5 vectors deleted of early region 1 (e1) undergo limited expression of early replicative e2 proteins and DNA replication in non-permissive cells","volume":"12","author":"Saha","year":"2017","journal-title":"PLoS ONE"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Crosby, C.M., Matchett, W.E., Anguiano-Zarate, S.S., Parks, C.A., Weaver, E.A., Pease, L.R., Webby, R.J., and Barry, M.A. (2017). Replicating single-cycle adenovirus vectors generate amplified influenza vaccine responses. J. Virol., 91.","DOI":"10.1128\/JVI.00720-16"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1093\/infdis\/jiy411","article-title":"A replicating single-cycle adenovirus vaccine against ebola virus","volume":"218","author":"Matchett","year":"2018","journal-title":"J. Infect. Dis."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/11\/5\/413\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:49:00Z","timestamp":1760186940000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/11\/5\/413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,3]]},"references-count":28,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,5]]}},"alternative-id":["v11050413"],"URL":"https:\/\/doi.org\/10.3390\/v11050413","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,3]]}}}